JW Pharmaceutical Corporation (KRX:001065)

Market Cap	517.05B
Revenue (ttm)	742.85B
Net Income (ttm)	50.08B
Shares Out	n/a
EPS (ttm)	2,156.98
PE Ratio	10.33
Forward PE	n/a
Dividend	475.00 (1.66%)
Ex-Dividend Date	Dec 27, 2024

Volume	215
Average Volume	236
Open	28,950
Previous Close	28,950
Day's Range	28,650 - 28,950
52-Week Range	25,050 - 31,700
Beta	1.07
RSI	41.74
Earnings Date	Aug 14, 2025

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,068
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001065

Financial Performance

In 2024, JW Pharmaceutical's revenue was 719.38 billion, a decrease of -3.89% compared to the previous year's 748.53 billion. Earnings were 60.78 billion, an increase of 64.24%.